Protinhi Therapeutics

About:

Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats.

Top Investors: European Innovation Council

Description:

Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats like dengue, westnilevirus, covid etc.

Total Funding Amount:

2.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nijmegen, Gelderland, The Netherlands

Founded Date:

2013-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-10-05

IPO Status:

Private

Industries: